(RTTNews) - Arcutis Biotherapeutics (ARQT) announced new data on ZORYVE (roflumilast) and research on long-term topical corticosteroid use presented at the EADV Congress and Fall Clinical Dermatology Conference.
The NASDAQ 100 Pre-Market Indicator is up 219.71 to 30,945.52. The total Pre-Market volume is currently 70,554,536 shares traded.The following are the most active stocks for the pre-market session: Space Exploration Technologies Corp. (SPCX) is +6.03 at $166.60, with 4,173,303 s
(RTTNews) - Glaukos Corporation (GKOS) reported positive topline results from a Phase 4 prospective randomized, controlled study evaluating iDose TR administered alongside cataract surgery in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).
The S&P 500 Index ($SPX ) (SPY ) closed down by -0.47% on Thursday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.39%. December E-mini S&P futures (ESZ26 ) fell -0.41%, and December E-mini...
Freeport-McMoRan (NYSE: FCX) and Southern Copper (NYSE: SCCO) could both benefit if copper stays tight, but for very different reasons. Freeport brings production growth and operating leverage, while Southern Copper brings enormous reserves and very low costs.
(RTTNews) - Johnson & Johnson (JNJ), a healthcare company focused on innovative medicines and medical technologies, reported two-year results from the Phase 3 ICONIC-LEAD study of ICOTYDE (icotrokinra) in adults and adolescents aged 12 years and older with moderate-to-severe plaq
(RTTNews) - Alumis (ALMS) announced envudeucitinib data from the ONWARD Phase 3 clinical program—ONWARD1, ONWARD2, and the long-term extension ONWARD3. The company said the results reinforced the potential of envudeucitinib to become a leading oral therapy for patients with moder
Fintel reports that on October 9, 2026, Baird upgraded their outlook for Humana (NYSE:HUM) (XTRA:HUM) from Neutral to Outperform.Humana Inc., based in the United States, operates primarily within the healthcare industry, focusing on health insurance services. The company manages
(RTTNews) - Friday, Glaukos Corporation (GKOS) announced positive topline results from a Phase 4 study evaluating iDose TR in combination with cataract surgery in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).
(RTTNews) - Avient Corp. (AVNT), a manufacturer of colorants, additives and polymers, announced Friday that its Board of Directors has appointed Mike Frank as President and Chief Executive Officer, effective immediately. Frank succeeds Ashish Khandpur, who has stepped down from h
Key PointsAMD, already past a $1 trillion market cap, needs about 70% more growth to pass Broadcom's $1.7 trillion, a target its OpenAI deal makes realistic.